BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1017 related articles for article (PubMed ID: 26043152)

  • 41. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.
    Abdel-Wahab M; Mehilli J; Frerker C; Neumann FJ; Kurz T; Tölg R; Zachow D; Guerra E; Massberg S; Schäfer U; El-Mawardy M; Richardt G;
    JAMA; 2014 Apr; 311(15):1503-14. PubMed ID: 24682026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: Device success, thirty-day safety, and mortality.
    Zhang Y; Pyxaras SA; Wolf A; Schmitz T; Naber CK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1217-25. PubMed ID: 25581785
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Percutaneous transcatheter aortic valve implantation for degenerated surgical bioprostheses: the first case series in Asia with one-year follow-up.
    Chiam PT; Ewe SH; Soon JL; Ho KW; Sin YK; Tan SY; Lim ST; Koh TH; Chua YL
    Singapore Med J; 2016 Jul; 57(7):401-5. PubMed ID: 27193081
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
    Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Importance of the left ventricular outflow tract in the need for pacemaker implantation after transcatheter aortic valve replacement.
    Rodríguez-Olivares R; van Gils L; El Faquir N; Rahhab Z; Di Martino LF; van Weenen S; de Vries J; Galema TW; Geleijnse ML; Budde RP; Boersma E; de Jaegere PP; Van Mieghem NM
    Int J Cardiol; 2016 Aug; 216():9-15. PubMed ID: 27135150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcatheter aortic valve implantation with the Edwards Sapien 3 valve: First experiences in Turkey.
    Aslan AN; Baştuğ S; Kasapkara HA; Ayhan H; Süygün H; Keleş T; Durmaz T; Akar Bayram N; Bilen E; Bozkurt E
    Turk Kardiyol Dern Ars; 2016 Dec; 44(8):663-669. PubMed ID: 28045412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Direct Comparison of Self-Expandable Portico Versus Balloon-Expandable Sapien 3 Devices for Transcatheter Aortic Valve Replacement: A Case-Matched Cohort Study.
    Mas-Peiro S; Seppelt PC; Weiler H; Mohr GL; Papadopoulos N; Walther T; Zeiher AM; Fichtlscherer S; Vasa-Nicotera M
    J Invasive Cardiol; 2019 Jul; 31(7):E199-E204. PubMed ID: 31257214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
    Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
    JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: an analysis from the multicentre German TAVI registry.
    Abdel-Wahab M; Zahn R; Gerckens U; Linke A; Sievert H; Schäfer U; Kahlert P; Hambrecht R; Sack S; Hoffmann E; Senges J; Schneider S; Richardt G;
    Heart; 2014 Aug; 100(16):1250-6. PubMed ID: 24895354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of Different Iterations of Devices and Degree of Aortic Valve Calcium on Paravalvular Regurgitation After Transcatheter Aortic Valve Implantation.
    Kong WK; van Rosendael PJ; van der Kley F; de Weger A; Kamperidis V; Regeer MV; Marsan NA; Bax JJ; Delgado V
    Am J Cardiol; 2016 Aug; 118(4):567-71. PubMed ID: 27328953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CT predictors of post-procedural aortic regurgitation in patients referred for transcatheter aortic valve implantation: an analysis of 105 patients.
    Marwan M; Achenbach S; Ensminger SM; Pflederer T; Ropers D; Ludwig J; Weyand M; Daniel WG; Arnold M
    Int J Cardiovasc Imaging; 2013 Jun; 29(5):1191-8. PubMed ID: 23420354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Edwards Sapien XT versus Lotus Valve Devices in Terms of Electrophysiological Study Parameters in Patients Undergoing TAVI.
    Eksik A; Yildirim A; Gul M; Aslan S; Tosu AR; Surgit O; Cakmak HA; Satilmisoglu MH; Akkaya E; Bakir I
    Pacing Clin Electrophysiol; 2016 Oct; 39(10):1132-1140. PubMed ID: 27418419
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transaortic transcatheter aortic valve implantation: Results of the Polish arm of the ROUTE registry.
    Jagielak D; Bramlage P; Pawlaczyk R; Brzeziński M; Fijałkowski M; Łaskawski G; Ciećwierz D; Rogowski J; Kozaryn R
    Cardiol J; 2015; 22(6):651-6. PubMed ID: 26202653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pitfalls in TAMVI: experience with the repositionable Lotus® Valve System.
    Heinisch PP; Praz F; Winkler B; Windecker S; Huber C; Carrel T
    J Cardiothorac Surg; 2017 Jun; 12(1):47. PubMed ID: 28606165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry.
    Staubach S; Franke J; Gerckens U; Schuler G; Zahn R; Eggebrecht H; Hambrecht R; Sack S; Richardt G; Horack M; Senges J; Steinberg DH; Ledwoch J; Fichtlscherer S; Doss M; Wunderlich N; Sievert H;
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):348-55. PubMed ID: 22566406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The incidence of transcatheter aortic valve implantation-related heart block in self-expandable Medtronic CoreValve and balloon-expandable Edwards valves.
    Liang M; Devlin G; Pasupati S
    J Invasive Cardiol; 2012 Apr; 24(4):173-6. PubMed ID: 22477754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transaortic transcatheter aortic valve implantation using SAPIEN XT or SAPIEN 3 valves in the ROUTE registry.
    Romano M; Frank D; Cocchieri R; Jagielak D; Bonaros N; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Arne Rein K; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Bapat V
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):757-764. PubMed ID: 28582580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transfemoral Transcatheter Aortic Valve-in-Valve Implantation for Aortic Valve Bioprosthesis Failure With the Fully Repositionable and Retrievable Lotus Valve: A Single-Center Experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    J Invasive Cardiol; 2017 Sep; 29(9):315-319. PubMed ID: 28706126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic value of aortic root calcification volume on clinical outcomes after transcatheter balloon-expandable aortic valve implantation.
    Watanabe Y; Lefèvre T; Bouvier E; Arai T; Hayashida K; Chevalier B; Romano M; Hovasse T; Garot P; Donzeau-Gouge P; Farge A; Cormier B; Morice MC
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):1105-13. PubMed ID: 25945689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conduction Abnormalities and Pacemaker Implantations After SAPIEN 3 Vs SAPIEN XT Prosthesis Aortic Valve Implantation.
    Husser O; Kessler T; Burgdorf C; Templin C; Pellegrini C; Schneider S; Kasel AM; Kastrati A; Schunkert H; Hengstenberg C
    Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):141-8. PubMed ID: 26542175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.